Svelta Labs Education & Research Journal
Fresh editorial content for peptide research, skincare science, wellbeing categories, Svelta-GPT updates, and research-use product guidance.
Obesity Prevention and the Food Environment: England’s Policy Debate
Food environments shape the choices available to people. This editorial examines Parliament’s proposed action on healthier sales, advertising and local access.
GLP-1 Side Effects: Common Symptoms and Important Safety Signals
Digestive symptoms are common with GLP-1 medicines, but some warnings are medicine-specific. Here is how to distinguish established risks from online anecdotes.
GLP-1 Medicines and Fat Graft Survival: What the Biology Suggests
A scoping review raises questions about incretin medicines and fat graft biology. Its mechanisms are hypotheses, not proof of poorer surgical outcomes.
FDA Peptide Panel Recommendations: What a Vote Can Change
Reports of favourable peptide-panel votes raised questions about access. The key distinction is between advisory recommendations, agency action and product approval.
Peptide Compounding Market: Regulation and Supply-Chain Readiness
Interest in peptide compounding raises supply-chain and market questions. An advisory recommendation is not a licence to manufacture approved medicines.
FDA Peptide Compounding Review: The Evidence and Safety Questions
The FDA’s July 2026 review concerned ingredients for pharmacy compounding. Its evidence questions differ from approval of a finished medicine.
What Are GLP-1 Receptor Agonists and How Do They Work?
Learn how GLP-1 medicines affect appetite and blood sugar, with examples and a clear distinction between diabetes and weight-management indications.
What Is Cagrilintide? Amylin, CagriSema and Weight-Loss Research
Cagrilintide is an investigational amylin analogue. This guide explains its appetite-related biology, CagriSema trials and the limits of current evidence.
Wolverine Peptide Pen Ingredients: Why the Name Needs Checking
The earlier article used Wolverine for BPC-157 and TB-500. Svelta’s current Wolverine Recovery Pen lists CJC-1295 no DAC and Ipamorelin, so the distinction matters.
Not Eating Enough During Weight Loss: When to Review Your Diet
Weight management should not mean ignoring nutrition. Review whether your meals meet your needs and seek help if low appetite or restrictive eating makes that difficult.
Weight Loss for Women Over 30: Building a Practical Routine
Work, family and health can all affect a routine. Focus on realistic changes and individual advice rather than a special protocol or a guaranteed result at a particular age.
Retatrutide and Fatty Liver: What the Phase 2a Trial Found
A phase 2a study measured liver fat in participants with metabolic dysfunction-associated steatotic liver disease. Its results need the study context and clear limits.